Handelsbanken Fonder AB Sells 1,000 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
Handelsbanken Fonder AB lessened its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 3.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,500 shares of the company’s stock after selling 1,000 shares during the quarter. Handelsbanken Fonder AB’s holdings in Beam […]
